REGENXBIO to Host RGX-314 Program Analyst and Investor Event with Leading Retina Specialists
The agenda will include discussion on
The program will feature key opinion leaders and retina specialists, including:
John Pollack , M.D.
Partner atIllinois Retina Associates , Assistant Professor of Ophthalmology atRush University Medical Center , and President of theAmerican Society of Retina Specialists (ASRS)Pravin U. Dugel , M.D.
Subspecialty Day Board Chairman Emeritus for theAmerican Academy of Ophthalmology (AAO), Board of Directors and Executive Committee of ASRS and Board of Trustees of EURETINA, Clinical Professor atRoski Eye Institute andUniversity of Southern California Keck School of Medicine , and Managing Partner atRetinal Consultants of Arizona ,Phoenix Jeffrey Heier , M.D.
Co-President, Medical Director and Retina Service Director ofRetina Research Ophthalmic Consultants ofBoston , and Principal Investigator of the RGX-314 Phase I/IIa clinical trialAllen C. Ho , M.D.Executive Committee of theRetina Society , Professor of Ophthalmology atSidney Kimmel Medical College atThomas Jefferson University , Director ofRetina Research atWills Eye Hospital , and Investigator in the RGX-314 Phase I/IIa clinical trial
For any inquiries, kindly reach out to
To access the live webcast, visit the Investors section of
About REGENXBIO
CONTACT:
Investors
heather@argotpartners.com
Media:
david.rosen@argotpartners.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/regenxbio-to-host-rgx-314-program-analyst-and-investor-event-with-leading-retina-specialists-300795415.html
SOURCE